GRTS News and Press, Gritstone Oncology Inc. From 04/04/24

NEW YORK, NY / ACCESSWIRE / April 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gritstone bio, Inc. ("Gritstone" or "the Company") (NASDAQ:GRTS). Investors who purchased Gritstone securities are encouraged to obtain additional infor...

2024-04-02 17:00:03 ET Kaveri Pohlman from BTIG issued a price target of $3.00 for GRTS on 2024-04-02 13:58:00. The adjusted price target was set to $3.00. At the time of the announcement, GRTS was trading at $1.2. The overall price target consensus is at $5.50 with high...

A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 43.8% to $0.1485 on volume of 202,621,744 shares Nikola Corporation (NKLA) fell 5.5% to $0.9736 on volume of 187,304,976 shares C3is Inc. (CISS) rose 13.3% to $0.0409 on volume of 136,767,990 shares ...

2024-04-02 13:01:35 ET Read the full article on Seeking Alpha For further details see: XTIA, TPET and GSIT among mid-day movers

A look at the top 10 most actives in the United States Trio Petroleum Corp. (TPET) rose 63.6% to $0.168949 on volume of 119,634,330 shares C3is Inc. (CISS) rose 17.5% to $0.0424 on volume of 56,452,737 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 6.6% to $3.315 on volume...

2024-04-02 10:00:25 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...

2024-04-02 08:37:57 ET More on Pre-market losers & stocks. Hut 8 Mining Corp. (HUT) Q4 2023 Earnings Call Transcript From Bull To Bear: Recent Events Drove Me To Exit My Position In HUT 8 Hut 8 Post-Merger Comprehensive Thesis: JCapital Research Might Be Right ...

2024-04-02 04:53:23 ET More on Gritstone bio Gritstone bio: Looking For Validation In 2024 Gritstone stock plunges 35% amid Phase 2 data, public offering Gritstone announces proposed public offering Read the full article on Seeking Alpha For further d...

EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced the pricing of an approximately $32.5 million underwritten public offering of its comm...

2024-04-01 16:55:25 ET More on Gritstone bio, Humana, etc. UnitedHealth Group: Buy The Recent Pullback - Long-Term Tailwinds Remain Excellent UnitedHealth Group: Optum To Drive Growth But Watch For Regulatory Risk Humana: This Year's Drop Might Have Created A Buying ...